Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1828 |
N-Acetyl-Ser-Asp-Lys-Pro
|
RAAS | Endocrinology/Hormones |
N-Acetyl-Ser-Asp-Lys-Pro 通过酶促处理胸腺素 β4 在骨髓细胞中形成。 它抑制多能造血干细胞进入细胞周期的 S 期,并防止小鼠中的 Ara-C 致死性。 | |||
TP1371 |
N-Acetyl-Ser-Asp-Lys-Pro TFA
|
||
N-Acetyl-Ser-Asp-Lys-Pro (TFA) is an endogenous tetrapeptide that is naturally produced in the bone marrow. It serves as a specific substrate for the N-terminal site of ACE, the enzyme responsible for angiotensin converting activity. | |||
T75752 |
N-Acetyl-Ser-Asp-Lys-Pro acetate
|
||
N-Acetyl-Ser-Asp-Lys-Pro (Ac-SDKP) acetate 是血管紧张素转换酶 (ACE) N 端活性位点的特异性底物。N-Acetyl-Ser-Asp-Lys-Pro acetate 是多能干细胞增殖的天然抑制剂。N-Acetyl-Ser-Asp-Lys-Pro acetate 具有抗炎和抗纤维化特性。 | |||
T28632 |
RXP-407
RXP407 |
||
RXP 407 is a selective inhibitor of the N-domain of angiotensin I-converting enzyme. RXP 407 blocks the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis in vivo. |